Millions of people around the world are involved in direct selling. There are 12 million in the United States alone! Almost 74 percent of direct sellers are...... more

Millions of people around the world are involved in direct selling. There are 12 million in the United States alone! Almost 74 percent of direct sellers are women. An estimated 46 million people in the world are involved in direct selling, according to the "Direct Selling Association." In less than ten years this number is expected to grow to an unbelievable 200 million! With more people looking for careers that offer independence, flexibility, and tremendous income potential, this book offers a one-stop source of nuts-and-bolts advice, insights, and practical sales skills. "Build It Big: 101 Insider Secrets from Top Direct Selling Experts" addresses the three most popular models of direct selling: * network marketing (e.g., "Amway") * party planning (e.g., "Pampered Chef") * person-to-person(e.g., "Guardian Life Insurance") The training that many of these companies offer is limited and typically covers only product features and benefits, basic sales techniques, recruitment, and order processing. Through extensive research, the "Direct Selling Women's Alliance" (DSWA) has identified four crucial ""life skills"" that often are neglected or omitted from a company's training and support program: * Financial and tax guidance. * Coaching and leadership skills development. * Business management and technology training. * Daily success practices and implementation. "Build It Big" unveils the methods and approaches in developing these skills that, DSWA believes, are the true linchpins of growth and long-term sales stability. The disciplined approach and real-life insights from some of the most successful and talented people in the direct selling business will have broad appeal to rookies and veterans alike, especially for people who are opting for direct selling for part-time work, extra income, and the autonomy it offers.

... less

Providers of early years care and education must provide their services in a safe and secure environment. Key to ensuring this, is a sound risk management...... more

Providers of early years care and education must provide their services in a safe and secure environment. Key to ensuring this, is a sound risk management process, which should become an integral part of a group's decision making and planning. Managing Risk provides guidance on each stage of the risk assessment process; the importance of developing a risk strategy, how to analyse hazards, as well as the insurance aspects. Also included are fire safety procedures and a fire safety risk assessment form.

... less

All practitioners within a childcare setting must take steps to prevent accidents, and when they do occur, respond quickly and appropriately to effectively...... more

All practitioners within a childcare setting must take steps to prevent accidents, and when they do occur, respond quickly and appropriately to effectively manage the impact of them. The Accident Record provides formatted pages for recording and guidance on, where appropriate, reporting accidents involving children, as part of the setting´s health and safety procedures. Ensuring accurate and consistent recording of accidents is important for informing parents, assessing risk, potential insurance claims and for reporting certain accidents to the Health and Safety Executive and Ofsted. An ambulance request form is also included.

... less

Millions of people around the world are involved in direct selling. There are 12 million in the United States alone! Almost 74 percent of direct sellers are...... more

Millions of people around the world are involved in direct selling. There are 12 million in the United States alone! Almost 74 percent of direct sellers are women. An estimated 46 million people in the world are involved in direct selling, according to the "Direct Selling Association." In less than ten years this number is expected to grow to an unbelievable 200 million! With more people looking for careers that offer independence, flexibility, and tremendous income potential, this book offers a one-stop source of nuts-and-bolts advice, insights, and practical sales skills. "Build It Big: 101 Insider Secrets from Top Direct Selling Experts" addresses the three most popular models of direct selling: * network marketing (e.g., "Amway") * party planning (e.g., "Pampered Chef") * person-to-person(e.g., "Guardian Life Insurance") The training that many of these companies offer is limited and typically covers only product features and benefits, basic sales techniques, recruitment, and order processing. Through extensive research, the "Direct Selling Women's Alliance" (DSWA) has identified four crucial ""life skills"" that often are neglected or omitted from a company's training and support program: * Financial and tax guidance. * Coaching and leadership skills development. * Business management and technology training. * Daily success practices and implementation. "Build It Big" unveils the methods and approaches in developing these skills that, DSWA believes, are the true linchpins of growth and long-term sales stability. The disciplined approach and real-life insights from some of the most successful and talented people in the direct selling business will have broad appeal to rookies and veterans alike, especially for people who are opting for direct selling for part-time work, extra income, and the autonomy it offers.

... less

United Kingdom released, PAL/Region 0 DVD: LANGUAGES: English ( Dolby Digital 2.0 ), SPECIAL FEATURES: Biographies, Featurette, Interactive Menu, Scene Access,...... more

United Kingdom released, PAL/Region 0 DVD: LANGUAGES: English ( Dolby Digital 2.0 ), SPECIAL FEATURES: Biographies, Featurette, Interactive Menu, Scene Access, SYNOPSIS: Paul Keller is a married pastor who preaches piety on Sunday, while carrying on a torrid affair with the local school teacher, Veronica Dow, during the week. The lovers concoct a scheme to fake Keller's death so that they can be together, but the plan goes awry when Keller hits his head and awakens not knowing who he is. A dazed Keller wanders into the motel he used for his secret liaisons, and is found by Charlene Hunt, a lonely and desperate motel manager, who realizes Keller has amnesia and makes him her prisoner and lover. In the interim, Keller's wife Martha is suspected of foul play by an insurance investigator and forges an unwitting alliance with Dow, her husband's lover. ...Amnesia (1996)

... less

Jack Ryan Jr. returns in "Locked On", the gripping new thriller from Tom Clancy. The Ryans - father and son - are fighting on two fronts...When a deadly...... more

Jack Ryan Jr. returns in "Locked On", the gripping new thriller from Tom Clancy. The Ryans - father and son - are fighting on two fronts...When a deadly terrorist alliance creates the potential to blackmail any world power into submission, it's got to be stopped before it is too late. That's just the trigger Jack Ryan Jr needs to take his work for shadowy intelligence agency The Campus from the back room to the sharp end: black ops. Meanwhile, his father, Jack Ryan Sr, campaigning for re-election as US President, is up against a privately funded vendetta to discredit him. Caught at the heart of the conspiracy is former Navy SEAL, John Clark. And Ryan Sr soon discovers that being his friends could have deadly consequences. With the breakneck speed and military action scenes that have made him the premier thriller writer of our time, Tom Clancy delivers a novel of high-tech warfare in which the enemy within may be even more devastating than the enemy without. "Locked On" follows the gripping "Dead or Alive" and "The Teeth of the Tiger" as the explosive third novel in Tom Clancy's "Jack Ryan Jr." series. Praise for Tom Clancy: "Truly riveting, a dazzling read". ("Sunday Express"). "A brilliantly constructed thriller". ("Daily Mail"). Thirty years ago, Tom Clancy was a Maryland insurance broker with a passion for naval history. His first novel, "The Hunt for Red October", catapulted on to "The New York Times" bestseller list after President Reagan pronounced it 'the perfect yarn'. Since then Clancy has established himself as an undisputed master at blending exceptional realism and authenticity, intricate plotting and razor-sharp suspense. Mark Greaney has a degree in international relations and political science and is pursuing his master's in intelligence studies with a concentration on criminal intelligence. He is the author of "The Gray Man", "On Target" and "Ballistic".

... less

United Kingdom released, PAL/Region 0 DVD: LANGUAGES: English ( Dolby Digital 2.0 ), SPECIAL FEATURES: Biographies, Featurette, Interactive Menu, Scene Access,...... more

United Kingdom released, PAL/Region 0 DVD: LANGUAGES: English ( Dolby Digital 2.0 ), SPECIAL FEATURES: Biographies, Featurette, Interactive Menu, Scene Access, SYNOPSIS: Paul Keller is a married pastor who preaches piety on Sunday, while carrying on a torrid affair with the local school teacher, Veronica Dow, during the week. The lovers concoct a scheme to fake Keller's death so that they can be together, but the plan goes awry when Keller hits his head and awakens not knowing who he is. A dazed Keller wanders into the motel he used for his secret liaisons, and is found by Charlene Hunt, a lonely and desperate motel manager, who realizes Keller has amnesia and makes him her prisoner and lover. In the interim, Keller's wife Martha is suspected of foul play by an insurance investigator and forges an unwitting alliance with Dow, her husband's lover. ...Amnesia (1996)

... less

The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges...... more

The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with 18 chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summariz

... less

Jack Ryan Jr. returns in "Locked On", the gripping new thriller from Tom Clancy. The Ryans - father and son - are fighting on two fronts...When a deadly...... more

Jack Ryan Jr. returns in "Locked On", the gripping new thriller from Tom Clancy. The Ryans - father and son - are fighting on two fronts...When a deadly terrorist alliance creates the potential to blackmail any world power into submission, it's got to be stopped before it is too late. That's just the trigger Jack Ryan Jr needs to take his work for shadowy intelligence agency The Campus from the back room to the sharp end: black ops. Meanwhile, his father, Jack Ryan Sr, campaigning for re-election as US President, is up against a privately funded vendetta to discredit him. Caught at the heart of the conspiracy is former Navy SEAL, John Clark. And Ryan Sr soon discovers that being his friends could have deadly consequences. With the breakneck speed and military action scenes that have made him the premier thriller writer of our time, Tom Clancy delivers a novel of high-tech warfare in which the enemy within may be even more devastating than the enemy without. "Locked On" follows the gripping "Dead or Alive" and "The Teeth of the Tiger" as the explosive third novel in Tom Clancy's "Jack Ryan Jr." series. Praise for Tom Clancy: "Truly riveting, a dazzling read". ("Sunday Express"). "A brilliantly constructed thriller". ("Daily Mail"). Thirty years ago, Tom Clancy was a Maryland insurance broker with a passion for naval history. His first novel, "The Hunt for Red October", catapulted on to "The New York Times" bestseller list after President Reagan pronounced it 'the perfect yarn'. Since then Clancy has established himself as an undisputed master at blending exceptional realism and authenticity, intricate plotting and razor-sharp suspense. Mark Greaney has a degree in international relations and political science and is pursuing his master's in intelligence studies with a concentration on criminal intelligence. He is the author of "The Gray Man", "On Target" and "Ballistic".

... less

The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges...... more

The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with 18 chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summariz

... less